These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38480469)

  • 21. Low-Density Lipoprotein Cholesterol Is Predominantly Associated With Atherosclerotic Cardiovascular Disease Events in Patients With Evidence of Coronary Atherosclerosis: The Western Denmark Heart Registry.
    Mortensen MB; Dzaye O; Bøtker HE; Jensen JM; Maeng M; Bentzon JF; Kanstrup H; Sørensen HT; Leipsic J; Blankstein R; Nasir K; Blaha MJ; Nørgaard BL
    Circulation; 2023 Apr; 147(14):1053-1063. PubMed ID: 36621817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Childhood Non-HDL Cholesterol and LDL Cholesterol and Adult Atherosclerotic Cardiovascular Events.
    Wu F; Juonala M; Jacobs DR; Daniels SR; Kähönen M; Woo JG; Sinaiko AR; Viikari JSA; Bazzano LA; Burns TL; Steinberger J; Urbina EM; Venn AJ; Raitakari OT; Dwyer T; Magnussen CG
    Circulation; 2024 Jan; 149(3):217-226. PubMed ID: 38014550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Independent Association of Lipoprotein(a) and Coronary Artery Calcification With Atherosclerotic Cardiovascular Risk.
    Mehta A; Vasquez N; Ayers CR; Patel J; Hooda A; Khera A; Blumenthal RS; Shapiro MD; Rodriguez CJ; Tsai MY; Sperling LS; Virani SS; Blaha MJ; Joshi PH
    J Am Coll Cardiol; 2022 Mar; 79(8):757-768. PubMed ID: 35210030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipoprotein(a) and coronary artery calcium in comparison with other lipid biomarkers: The multi-ethnic study of atherosclerosis.
    Jackson CL; Garg PK; Guan W; Tsai MY; Criqui MH; Tsimikas S; Bhatia HS
    J Clin Lipidol; 2023; 17(4):538-548. PubMed ID: 37357049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of Mobile-Based Cognitive Behavioral Therapy on Lowering Low-density Lipoprotein Cholesterol Levels in Patients With Atherosclerotic Cardiovascular Disease: Multicenter, Prospective Randomized Controlled Trial.
    Li D; Xu T; Xie D; Wang M; Sun S; Wang M; Zhang S; Yang X; Zhang Z; Wang S; Kuang M; Tang J; Liu H; Hong X; Fu G; Zhang W
    J Med Internet Res; 2023 Apr; 25():e44939. PubMed ID: 37043273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The correlation between lipoprotein(a) and coronary atherosclerotic lesion is stronger than LDL-C, when LDL-C is less than 104 mg/dL.
    Li C; Chen Q; Zhang M; Liu Y; Chu Y; Meng F; Wang J; Tang J; Luo J; Niu X; Wei M
    BMC Cardiovasc Disord; 2021 Jan; 21(1):41. PubMed ID: 33468066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of proprotein convertase subtilisin/kexin-9 monoclonal antibody treatment on plasma lipoprotein(a) concentrations in patients with elevated lipoprotein(a) attending a clinic.
    Chakraborty A; Pang J; Chan DC; Barnett W; Woodward AM; Vorster M; Watts GF
    Clin Cardiol; 2021 Jun; 44(6):805-813. PubMed ID: 33955565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Equivalent Impact of Elevated Lipoprotein(a) and Familial Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease.
    Hedegaard BS; Bork CS; Kaltoft M; Klausen IC; Schmidt EB; Kamstrup PR; Langsted A; Nordestgaard BG
    J Am Coll Cardiol; 2022 Nov; 80(21):1998-2010. PubMed ID: 36396201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can Lp(a) Lowering Against Background Statin Therapy Really Reduce Cardiovascular Risk?
    Reiner Ž
    Curr Atheroscler Rep; 2019 Mar; 21(4):14. PubMed ID: 30847681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients.
    Longenecker JC; Klag MJ; Marcovina SM; Liu YM; Jaar BG; Powe NR; Fink NE; Levey AS; Coresh J
    J Am Soc Nephrol; 2005 Jun; 16(6):1794-802. PubMed ID: 15800123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipoprotein(a) and functional outcome of acute ischemic stroke when discordant with low-density lipoprotein cholesterol.
    Dong W; Zhong X; Yuan K; Miao M; Zhai Y; Che B; Xu T; Xu X; Zhong C
    Postgrad Med J; 2023 Oct; 99(1177):1160-1166. PubMed ID: 37624118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trajectories of Blood Lipid Concentrations Over the Adult Life Course and Risk of Cardiovascular Disease and All-Cause Mortality: Observations From the Framingham Study Over 35 Years.
    Duncan MS; Vasan RS; Xanthakis V
    J Am Heart Assoc; 2019 Jun; 8(11):e011433. PubMed ID: 31137992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of clonal haematopoiesis on atherosclerotic cardiovascular disease according to low-density lipoprotein cholesterol levels in general population.
    Lee H; Song H; Choi SY; Koh Y; Ryu G; Park HE; Yoon JW; Kim MJ; Chung S; Bae JH; Choi SH; Koo BK
    Eur J Prev Cardiol; 2024 Jul; 31(9):1162-1171. PubMed ID: 38349357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipoprotein(a) and mortality-a high risk relationship.
    Klingel R; Heibges A; Fassbender C
    Clin Res Cardiol Suppl; 2019 Apr; 14(Suppl 1):13-19. PubMed ID: 30838554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoprotein(a) and Family History Predict Cardiovascular Disease Risk.
    Mehta A; Virani SS; Ayers CR; Sun W; Hoogeveen RC; Rohatgi A; Berry JD; Joshi PH; Ballantyne CM; Khera A
    J Am Coll Cardiol; 2020 Aug; 76(7):781-793. PubMed ID: 32792075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adding ezetimibe to statin therapy: latest evidence and clinical implications.
    Vavlukis M; Vavlukis A
    Drugs Context; 2018; 7():212534. PubMed ID: 30023003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study.
    Quispe R; Martin SS; Michos ED; Lamba I; Blumenthal RS; Saeed A; Lima J; Puri R; Nomura S; Tsai M; Wilkins J; Ballantyne CM; Nicholls S; Jones SR; Elshazly MB
    Eur Heart J; 2021 Nov; 42(42):4324-4332. PubMed ID: 34293083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study.
    Ikezaki H; Lim E; Cupples LA; Liu CT; Asztalos BF; Schaefer EJ
    J Am Heart Assoc; 2021 Feb; 10(5):e019140. PubMed ID: 33586462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Burden of elevated lipoprotein(a) among patients with atherosclerotic cardiovascular disease: Evidence from a systematic literature review and feasibility assessment of meta-analysis.
    Orfanos P; Fonseca AF; Hu X; Gautam R; Montgomery G; Studer R; Kaur J; Saxena N; Kaushik N
    PLoS One; 2023; 18(11):e0294250. PubMed ID: 37983217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of lipoprotein(a) in atherosclerotic cardiovascular disease: A review of current and emerging therapies.
    Alhomoud IS; Talasaz A; Mehta A; Kelly MS; Sisson EM; Bucheit JD; Brown R; Dixon DL
    Pharmacotherapy; 2023 Oct; 43(10):1051-1063. PubMed ID: 37464942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.